Impairment by Mucosal Adjuvants and Cross-Reactivity with Variant Peptides of the Mucosal Immunity Induced by Injection of the Fusion Peptide PADRE-ELDKWA

Por Decroix, Nipa, Pamonsinlapatham, Perayot, Quan, Cahn P., Bouvet, Jean-Pierre
Publicado em 2003

HCV RNA decline in the first 24 hours exhibits high negative predictive value of sustained virologic response in HIV/HCV genotype 1 co-infected patients treated with peginterferon...

Por Laufer, N, Bolcic, F, Rolón, MJ, Martinez, A, Reynoso, R, Pérez, H, Salomón, H, Cahn, P, Quarleri, J
Publicado em 2011

Improving care for women living with HIV: initial outcomes of an integration experience

Por Fink, V, Zurita, D, Tejo, M, Perez, H, Cesar, C, Figueroa, M, Patterson, P, Sued, O, Cahn, P
Publicado em 2012

Clinical-epidemiological features of HIV-infected patients diagnosed at age of 50 years or older

Por Patterson, P, Cahn, S, Sued, O, Fink, V, Figueroa, M, Cesar, C, Rojo, M, Ben, G, Vázquez, M, Cahn, P
Publicado em 2012

Hepatitis B Virus Genotype Distribution and Its Lamivudine-Resistant Mutants in HIV-Coinfected Patients with Chronic and Occult Hepatitis B

Por Quarleri, J., Moretti, F., Bouzas, M.B., Laufer, N., Carrillo, M. Gómez, Giuliano, S. Fernández, Pérez, H., Cahn, P., Salomon, H.
Publicado em 2007

Plasma cytokine levels and HIV-specific immune responses during acute/early HIV infection

Por Turk, G, Laufer, N, Rodriguez, AM, Ghiglione, Y, Favilene, J, Ruiz, MJ, Sued, O, Giavedoni, L, Cahn, P, Salomon, H, Gherardi, MM
Publicado em 2012

Serologic evaluation of human immunodeficiency virus type 1-infected individuals from Argentina and the United States indicates a similar distribution of subgroup B isolates.

Por Warren, R Q, Wong, M T, Melcher, G P, Blatt, S P, Cahn, P, Perez, H, Zapiola, I, Bouzas, M B, Muchinik, G, Anderson, S A
Publicado em 1995

Efficacy, safety and tolerability of tipranavir co-administered with ritonavir in HIV-1-infected children and adolescents

Por Salazar, J.C., Cahn, P., Yogev, R., Negra, M. Della, Castelli-Gattinara, G., Fortuny, C., Flynn, P., Giaquinto, C., Ruan, P., Smith, M., Mikl, J., Jelaska, A.
Publicado em 2008

Pooled week 48 safety and efficacy results from the ECHO and THRIVE phase III trials comparing TMC278 vs EFV in treatment-naïve, HIV-1-infected patients

Por Cohen, C, Molina, JM, Cahn, P, Clotet, B, Fourie, J, Grinsztejn, B, Hao, W, Johnson, M, Supparatpinyo, K, Crauwels, HM, Rimsky, L, Vanveggel, S, Williams, P, Boven, K
Publicado em 2010

Prioritising prevention strategies for patients in Antiretroviral Treatment Programmes in Resource-Limited Settings

Por SPAAR, A., GRABER, C., DABIS, F., COUTSOUDIS, A, BACHMANN, L., MCINTYRE, J., SCHECHTER, M., PROZESKY, H.W., TUBOI, S., DICKINSON, D., KUMARASAMY, N., PUJDADES-RODRIQUEZ, M., SPRINZ, E., SCHILTHUIS, H.J., CAHN, P., LOW, N., EGGER, M.
Publicado em 2010